Vincerx Pharma, Inc. Share-based Payment Arrangement, Noncash Expense
Vincerx Pharma, Inc. reported Share-based Payment Arrangement, Noncash Expense of $2.29 million for the 3-month period ending 2022-09-30, per its 10-Q filed 2022-11-10.
Discontinued › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2022-11-10
- Vincerx Pharma, Inc. share-based payment arrangement, noncash expense for the quarter ending 2022-09-30 was $2.29M, a 62.30% decline year-over-year.
- Vincerx Pharma, Inc. share-based payment arrangement, noncash expense for the quarter ending 2022-06-30 was $3.36M, a 49.34% decline year-over-year.
- Vincerx Pharma, Inc. share-based payment arrangement, noncash expense for the quarter ending 2022-03-31 was $5.26M, a 11.52% increase year-over-year.
- Vincerx Pharma, Inc. share-based payment arrangement, noncash expense for the quarter ending 2021-09-30 was $6.08M.
| Period end | Share-based Payment Arrangement, Noncash Expense 0 month | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month |
|---|---|---|---|---|
| 2022-09-30 | $2.29M 10-Q · filed 2022-11-10 | $5.65M derived: sum of 2 quarters · filed 2022-11-10 | $10.91M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $3.36M 10-Q · filed 2022-08-11 | $8.62M 10-Q · filed 2022-08-11 | ||
| 2022-03-31 | $5.26M 10-Q · filed 2022-05-12 | |||
| 2021-09-30 | $6.08M 10-Q · filed 2022-11-10 | $12.71M derived: sum of 2 quarters · filed 2022-11-10 | $17.43M 10-Q · filed 2022-11-10 | |
| 2021-06-30 | $6.64M 10-Q · filed 2022-08-11 | $11.35M 10-Q · filed 2022-08-11 | ||
| 2021-03-31 | $4.71M 10-Q · filed 2022-05-12 | |||
| 2021-01-05 | $17.43M 10-Q · filed 2021-11-12 |